生物靶标智能纳米机器人
| 【Numbering】BKME115006 | 【CAS】CAS | ||
| 【Item No.】BKME115006-2 | 【specification】 | ||
|
|||
Name: Biological target intelligent nanorobot
Composition: drug, signal label, target clamp target validator, intelligent cluster path controller and self-assembly motor
Grain size: 20-200nm
Application: Analytical chemistry, medical diagnosis, and disease treatment
Storage conditions: -4℃
Other instructions: Half shelf life in sealed state [Main advantages] achieve nonlinear cascade amplification of specific biological target signals or enrichment of accessory loads; indicating the application potential of intelligent DNA molecular nanorobots in biosensing, biological imaging and drug delivery
Message
Composition: drug, signal label, target clamp target validator, intelligent cluster path controller and self-assembly motor
Grain size: 20-200nm
Application: Analytical chemistry, medical diagnosis, and disease treatment
Storage conditions: -4℃
Other instructions: Half shelf life in sealed state [Main advantages] achieve nonlinear cascade amplification of specific biological target signals or enrichment of accessory loads; indicating the application potential of intelligent DNA molecular nanorobots in biosensing, biological imaging and drug delivery
Title:Intelligent and Robust DNA Robots Capable of Swarming into Leakless Nonlinear Amplification in Response to Trigger
Article link:https://hospital.hf.cas.cn/hfzl/xwzx_2019/yyxw_2019/202205/t20220517_700501.html
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance |
Message
|
| Warm tips: Suzhou Beike nano products are only used for scientific research, not for human body,different batches of products have different specifications and performance.The website pictures are from the Internet. The pictures are for reference only. Please take the real object as the standard. In case of infringement, please contact us to delete them immediately. |
Previous： the end...
Next： DIRAs
